A leader of domestic pharmaceutical market, Farmak JSC has expanded its Corvalol sedative line with launching of Corvalol N Drops of mild sedative effect.
Farmak JSC has been manufacturing the original Corvalol for virtually half a century, continuously expanding the product line. Thus, in early 2013 the Company introduced to the market Corvalol tablets. In early autumn this year Corvalol N Drops (25 ml), a new product, was added to the manufacturer’s pharmaceutical products portfolio.
Oksana Stepanchuk, Marketing Consultant of Farmak OTC Product Marketing Department says, “Corvalol N Drops have mild sedative effect and reduce manifestations of stress and nervous tension. The medicine composition includes ethyl ether of α-bromoisovaleric acid, peppermint oil, and hop oil.
The medicine is recommended for neurosis with increased irritability, enterospasm, mild coronary vessel spasm, tachycardia, and complex therapy of arterial hypertension and vegetovascular dystonia”.
In total, the Fund donated over UAH 4 million to fight the COVID-19 pandemic in the Ruzhynskyi district, as well as to reconstruct and equip a first-aid post in Nemyryntsi village As part of the anti-pandemic campaign, the Zhebrivski Family Charitable Foundation provided the Municipal Non-Commercial Enterprise “District Central Hospital” of the Ruzhynskyi Di...
The video presents a story of a typical day of several Farmak employees who get up before dawn, take care of their loved ones and go to work to fulfil an important mission. In such a simple form, the director portrayed Farmak as the Company with a soul, where employees are ordinary people, with their […]
Forbes included CEO of Farmak Volodymyr Kostiuk to the rating of the best directors of Ukraine. Twelve years ago, Volodymyr started his career at Farmak as Assistant to General Director, later he held a position in the Finance Division, worked on the SAP system, and in 2018 became the Company’s CEO. Due to the implemented […]